Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

by Katharina Gohr, Alexandra Hamacher, Laura H. Engelke, Matthias U. Kassack
Published 2017-11-01

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines

by Jan J. Bandolik, Alexandra Hamacher, Christian Schrenk, Robin Weishaupt, Matthias U. Kassack
Published 2019-06-01

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

by Ana J. Rodrigues Moita, Jan J. Bandolik, Finn K. Hansen, Thomas Kurz, Alexandra Hamacher, Matthias U. Kassack
Published 2020-11-01

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1

by Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz, Matthias U. Kassack
Published 2020-02-01

Cryptic Secondary Metabolites from the Sponge-Associated Fungus <i>Aspergillus ochraceus</i>

by Marian Frank, Ferhat Can Özkaya, Werner E. G. Müller, Alexandra Hamacher, Matthias U. Kassack, Wenhan Lin, Zhen Liu, Peter Proksch
Published 2019-02-01